Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes    » A1c    » Adolescents    » Awareness    » Cause    » Children    » Complications    » Control    » Costs    » Cure    » Diagnosis    » Drugs    » Elderly    » Gestational    » Hypoglycemia    » Impaired Fasting Glucose    » Impaired Glucose Tolerance    » Inflammation    » Insulin Resistance    » Insulin Sensitivity    » Men    » Metabolic Syndrome    » Minorities    » Obesity    » Organs    » Other Diseases    » Pancreas    » Pre-Diabetes    » Prevention    » Research    » Risk Factors    » Screening    » Statistics    » Stress    » Syndrome X    » Testing    » Treatments    » Type 1    » Type 2    » Warning Signs    » Women Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

About Diabetes » Obesity

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Acomplia ™(Rimonabant) Receives 1st Marketing Authorization in North America Posted: Thursday, November 16, 2006

Acomplia™ (rimonabant) approved in Mexico to treat obese/overweight patients with associated type 2 diabetes or dyslipidemia or to help them improve glycemic control on background of conventional antidiabetic treatment.

Diabetes Gene Carries Similar Risk to Obesity Posted: Thursday, November 09, 2006

Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.

Metformin Therapy Is Effective in Nonobese Patients With Type 2 Diabetes Posted: Thursday, November 09, 2006

There is now evidence-based data to support metformin use in nonobese individuals with type 2 diabetes."

Diabetes Gene Carries Similar Risk to Obesity Posted: Thursday, November 02, 2006

Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese.

Diet Drug Acomplia Seen Needing More Testing as Diabetes Treatment Posted: Thursday, November 02, 2006

Sanofi's highly anticipated diet drug Acomplia (rimonabant) may also be useful in helping obese diabetics control their blood sugar levels, but some respected researchers have expressed skepticism and called for additional testing in the prestigious British medical journal Lancet.

Pramlintide Continues Trials for Weight Loss Posted: Thursday, November 02, 2006

Results of a Phase 2 study show a 8% reduction in weight. Pramlintide shows weight loss for those even without diabetes.

Breast-Feeding Protects Against Obesity in Children of Diabetic, Overweight Mothers Posted: Wednesday, October 25, 2006

Breast-feeding is inversely associated with the risk of childhood obesity regardless of maternal diabetes status or weight status.

FDA Approves Januvia for Diabetes Posted: Thursday, October 19, 2006

The FDA announced the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors that enhances the body's own ability to lower elevated blood sugar.

Diabetes, Not Obesity, Increases Critical Illness and Death Risk Posted: Thursday, October 19, 2006

Diabetes is a strong predictor of acute organ failure and early death for obese or non-obese patients alike, eclipsing even obesity without diabetes, according to researchers.

Effect of Weight Loss on Arterial Stiffness in Type 2 Diabetes Posted: Thursday, October 12, 2006

Moderate weight loss improves arterial stiffness in type 2 diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.